Neonatal respiratory distress syndrome (RDS): nursing reference

Respiratory distress syndrome (RDS) is the most common serious lung disorder of the preterm newborn, affecting roughly 1% of all live births but up to 70% of infants born at 28 weeks or less. It is caused by a developmental deficiency of pulmonary surfactant — a lipid-protein mixture that reduces alveolar surface tension and prevents alveolar collapse at end-expiration. Without adequate surfactant, the work of breathing escalates rapidly with each breath, alveoli collapse, gas exchange fails, and hypoxemia progresses to respiratory failure.

This reference covers the pathophysiology, clinical recognition, diagnostic criteria, respiratory support ladder, surfactant replacement therapy, oxygen targeting, complications, and nursing interventions that matter most for NCLEX and NICU practice. It also addresses the 34–36 week transition zone — where RDS risk drops sharply but late preterm infants remain vulnerable — and the distinction between RDS and transient tachypnea of the newborn (TTN), a common NCLEX discriminator.

For the broader context of neonatal assessment and common diagnoses, see the neonatal nursing reference. For resuscitation in the delivery room, see neonatal resuscitation nursing. For the obstetric perspective on preterm birth management including antenatal steroid administration, see preterm labor nursing.

Surfactant deficiency: the core pathophysiology

Pulmonary surfactant is produced by Type II pneumocytes — specialized alveolar epithelial cells that differentiate from Type I pneumocytes during fetal lung development. Surfactant production begins around 20 weeks of gestation but does not reach functionally adequate levels until approximately 34–36 weeks. The primary surface-active component is phosphatidylcholine (lecithin), which — together with phosphatidylglycerol, sphingomyelin, and four surfactant-specific proteins (SP-A, SP-B, SP-C, SP-D) — reduces surface tension at the air-liquid interface inside the alveolus.

The relationship between surfactant sufficiency and gestational age is inverse: the younger the infant, the higher the risk. At 24–26 weeks, Type II pneumocytes are still immature and surfactant production is minimal. By 30–32 weeks, production is increasing but storage is limited. The 34–36 week window is the transition zone — most infants at 36 weeks have adequate surfactant, but late preterm infants at 34–35 weeks still carry meaningful RDS risk, particularly after cesarean delivery (which bypasses the catecholamine surge of labor that helps clear lung fluid and stimulate surfactant release).

Without surfactant, surface tension at the alveolar air-liquid interface is high. According to the Law of Laplace, the smaller the alveolus, the greater the collapsing pressure required to keep it open. Surfactant-deficient alveoli collapse at end-expiration (a process called atelectasis), and the infant must generate enormous negative intrathoracic pressure with each breath to re-inflate them from a collapsed state. This is exhausting work for a preterm infant with a compliant chest wall, weak respiratory muscles, and limited glycogen stores. Over the first 6–24 hours, respiratory effort increases progressively, CO2 rises, pH falls, and — without intervention — respiratory failure ensues.

Clinical signs and recognition

RDS presents within the first few hours of life, often in the delivery room. The classic clinical signs reflect the infant’s attempts to maintain alveolar patency and maximize gas exchange under conditions of low lung compliance.

Severity progresses over the first 24–72 hours in untreated RDS. Without surfactant therapy, the Silverman-Anderson retraction score or Downes score is used to grade distress and guide escalation decisions. With surfactant administration, improvement is typically seen within 30–60 minutes of dosing.

Diagnosis

RDS is a clinical and radiographic diagnosis. No single test is pathognomonic, but the combination of prematurity, clinical signs, and chest X-ray findings is usually definitive.

Chest X-ray (CXR): The classic pattern is ground-glass opacity — a fine, reticular (granular) haziness distributed uniformly across both lung fields. Air bronchograms are visible because the fluid-filled alveoli surrounding air-filled bronchi make the airways visible as dark linear streaks on the hazy background. Severe RDS shows a “white-out” pattern where lung opacity approaches that of the cardiac silhouette, making cardiac borders difficult to distinguish. This CXR pattern, combined with prematurity and clinical signs, confirms RDS.

Arterial blood gas (ABG): ABG in RDS shows a combined respiratory and metabolic acidosis. Expect hypoxemia (low PaO2), hypercapnia (elevated PaCO2) due to CO2 retention from alveolar hypoventilation, and acidosis (low pH). As respiratory failure progresses, the metabolic component worsens due to lactic acidosis from hypoperfusion.

SpO2 monitoring: Continuous pulse oximetry is mandatory. Target range for preterm infants (<37 weeks) is SpO2 91–95%. The rationale for this narrow band is discussed in the oxygen targeting section below.

Blood cultures: RDS and Group B streptococcal (GBS) pneumonia/sepsis can be clinically and radiographically indistinguishable. Blood cultures are drawn before empiric antibiotic initiation in virtually all infants with respiratory distress at birth. For neonatal sepsis management principles, see neonatal sepsis nursing.

Respiratory support ladder

Management of RDS follows a stepwise escalation of respiratory support, beginning with the least invasive effective modality. The goal at every step is to maintain adequate oxygenation and ventilation while minimizing barotrauma, volutrauma, and oxygen toxicity.

The key NCLEX teaching point: Nasal CPAP is the first-line respiratory support for moderate RDS — not immediate intubation. The European Consensus Guidelines on RDS management and AAP recommendations both support early nasal CPAP as the preferred non-invasive support mode, with selective surfactant via the INSURE technique preferred over prophylactic intubation for infants who stabilize on CPAP.

Surfactant replacement therapy

Exogenous surfactant administration is the cornerstone of RDS treatment. All surfactant preparations available in the US are derived from animal sources (porcine or bovine lung extract) and contain the phospholipids and surfactant proteins (SP-B and SP-C) required for surface tension reduction.

Prophylactic vs. rescue administration: Prophylactic surfactant is given within the first 30 minutes of life to very preterm infants (<28–29 weeks) who are intubated for respiratory failure or who are at very high RDS risk. Rescue surfactant is given after RDS is clinically established, typically once the FiO2 requirement on CPAP exceeds 30–40% or clinical signs of moderate-severe distress are confirmed. Current evidence supports the INSURE approach for most infants — brief intubation for surfactant, then rapid extubation to CPAP — over prolonged mechanical ventilation.

Administration technique and post-dose nursing actions:

1. Pre-medicate for pain/comfort per unit protocol (surfactant instillation via ETT is uncomfortable).
2. Confirm ETT position with CXR or capnography before dosing.
3. Warm surfactant to room temperature — do not shake vigorously.
4. Administer in divided aliquots (e.g., two halves with brief position changes) to promote distribution.
5. After dosing, monitor for rapid improvement in lung compliance — this is the most critical immediate post-dose nursing action. As surfactant takes effect, the lungs become more compliant; tidal volumes delivered by the ventilator increase, and if ventilator settings are not adjusted, the infant may develop hyperinflation or barotrauma.
6. ETT displacement risk increases immediately after dosing — the bolus of liquid can shift tube position. Reassess breath sounds bilaterally and monitor SpO2 and CO2 waveform continuously.
7. Avoid suctioning for 1–2 hours after surfactant administration (removes the just-instilled medication).

Oxygen targeting: the 91–95% window

Oxygen targeting in preterm infants requires balancing two competing risks.

Hypoxia risk (SpO2 <88%): Persistent hypoxemia causes pulmonary hypertension, impairs cardiac function, promotes anaerobic metabolism and metabolic acidosis, and — in severe cases — causes end-organ injury to the brain, kidneys, and gut. IVH risk is increased with hypoxic episodes.

Hyperoxia risk (SpO2 >95%): Excess oxygen in the premature lung generates free radicals that injure the developing respiratory epithelium, promoting bronchopulmonary dysplasia (BPD). In the developing retina, hyperoxia causes vasoconstriction of the immature retinal vessels followed by pathological neovascularization — the mechanism behind retinopathy of prematurity (ROP). The SUPPORT trial and subsequent meta-analyses established that targeting SpO2 91–95% in infants under 37 weeks reduces ROP without increasing mortality, compared to higher ranges (95–99%).

The nurse’s role in oxygen targeting is to maintain continuous SpO2 monitoring, respond promptly to alarms in both directions, and communicate FiO2 titration needs to the team. Oxygen is a drug — document FiO2 changes exactly as you would any medication adjustment.

Antenatal corticosteroids

The single most effective intervention for reducing RDS incidence and severity occurs before birth. Antenatal corticosteroids — betamethasone 12 mg IM x2 doses, 24 hours apart, or dexamethasone 6 mg IM x4 doses, 12 hours apart — are administered to mothers at risk of preterm delivery between 24 and 34 weeks of gestation.

Mechanism: corticosteroids cross the placenta and bind to glucocorticoid receptors in fetal Type II pneumocytes, accelerating differentiation and surfactant phospholipid synthesis. They also promote lung fluid reabsorption and structural maturation of the alveolar architecture.

Timing matters: The optimal benefit window is 24 hours to 7 days after the first dose. A full course administered more than 7 days before delivery provides diminishing protection. A course initiated less than 24 hours before delivery provides some benefit (especially for infants <28 weeks) but is incomplete. When preterm delivery appears imminent, corticosteroids are started immediately — even if delivery might occur within hours — because partial exposure is better than none.

Evidence: A full course of antenatal corticosteroids reduces RDS incidence by approximately 50%, reduces severity in infants who develop RDS, and independently reduces IVH, NEC, and neonatal mortality. This is one of the most robustly supported interventions in perinatal medicine.

Nurses caring for patients at risk of preterm birth should confirm antenatal steroid administration status on admission and advocate for administration if criteria are met but steroids have not been given. For the full obstetric management context, see preterm labor nursing.

Complications of RDS

Infants with RDS — particularly those who are extremely preterm or who require prolonged mechanical ventilation — are at risk for several serious complications.

Bronchopulmonary dysplasia (BPD): The most common chronic complication of RDS. Defined as oxygen dependency at 36 weeks corrected gestational age (or at 28 days of life in near-term infants). Caused by a combination of lung immaturity, oxygen toxicity, and ventilator-induced injury (barotrauma and volutrauma). BPD ranges from mild (oxygen requirement only) to severe (high-flow oxygen or positive pressure dependency). Prevention strategies include gentle ventilation, early CPAP, and targeted surfactant use.

Air leak syndromes: Pulmonary interstitial emphysema (PIE), pneumothorax, pneumomediastinum, and pneumopericardium can all occur when high ventilator pressures or auto-PEEP causes alveolar rupture. PIE — air tracking into the pulmonary interstitium — appears on CXR as linear or cystic lucencies and markedly worsens gas exchange. Pneumothorax presents with sudden deterioration, decreased breath sounds on the affected side, and mediastinal shift. Transillumination of the chest at the bedside and urgent CXR confirm the diagnosis. For a detailed review of pneumothorax management, see pneumothorax nursing.

Intraventricular hemorrhage (IVH): Hemorrhage into the germinal matrix — a highly vascular, fragile subependymal zone present in preterm brains — is a major complication of prematurity. Hypoxia, hypercapnia, rapid fluid shifts, and wide swings in blood pressure all contribute to IVH risk. Grades III and IV IVH carry significant risks of long-term neurodevelopmental impairment. Minimal stimulation protocols, head midline positioning, and careful blood pressure management are nursing priorities.

Necrotizing enterocolitis (NEC): Inflammatory necrosis of the intestinal wall, most common in preterm infants. Hypoxia and hypoperfusion from RDS reduce intestinal perfusion and impair mucosal barrier function, increasing NEC risk. For glucose management in the preterm neonate — a related vulnerability — see neonatal hypoglycemia nursing.

Retinopathy of prematurity (ROP): Pathological retinal neovascularization triggered by hyperoxia (and subsequent relative hypoxia). Severity ranges from mild (spontaneous regression) to severe (retinal detachment and blindness). Prevention relies on strict oxygen targeting (SpO2 91–95%). All infants under 30 weeks or under 1,500 g are screened by ophthalmology at 31–33 weeks corrected age.

Patent ductus arteriosus (PDA): The ductus arteriosus normally closes in response to rising oxygen levels after birth. In preterm infants with hypoxemia, the ductus may remain open, creating a left-to-right shunt that worsens pulmonary congestion and increases ventilator requirements. A hemodynamically significant PDA is treated with indomethacin, ibuprofen, or surgical ligation.

RDS vs. TTN: the NCLEX discriminator

Transient tachypnea of the newborn (TTN) is the most common cause of respiratory distress in the term newborn and is frequently tested alongside RDS on NCLEX. Both present with tachypnea and respiratory distress, but the pathophysiology, time course, CXR findings, and management differ substantially.

The key clinical rule for NCLEX: if the question says the baby is getting worse over the first 48–72 hours and has a ground-glass CXR, think RDS. If the baby is getting better by itself on room air or low-flow O2 and was born by cesarean at term, think TTN.

Nursing interventions

Nursing care of an infant with RDS integrates respiratory monitoring, thermoregulation, minimal stimulation, and family support into a coherent bedside approach.

Thermoregulation: Preterm infants have minimal subcutaneous fat, a high surface-area-to-volume ratio, and immature thermoregulatory mechanisms. Cold stress dramatically increases oxygen consumption and worsens acidosis, which further impairs surfactant function. Maintain temperature in a radiant warmer (acute phase) or double-walled isolette (once stable). Target axillary temperature 36.5–37.5°C. For transport within the unit, use pre-warmed transport isolette.

Minimal stimulation: Handling and stimulation increase oxygen consumption and can precipitate hypoxic episodes, bradycardia, and IVH in fragile preterm infants. Cluster care activities — group assessments, blood draws, diaper changes, and position changes — to allow adequate rest between interventions. Post signs at the bedside and communicate the minimal-stimulation plan to all team members and families.

Positioning: Prone positioning improves ventilation-perfusion matching in intubated infants and can reduce the work of breathing; however, prone positioning requires continuous monitoring and is generally used only in the ventilated or continuously monitored setting in the NICU. The nurse is responsible for verifying the rationale and safety checks for each infant’s positioning order.

Work of breathing documentation: At every assessment, document the presence or absence of grunting, nasal flaring, intercostal retractions, subcostal retractions, and suprasternal retractions. Record respiratory rate, oxygen requirement (FiO2), SpO2, and ventilator parameters. Trends across assessments are often more informative than any single data point.

Parental support and skin-to-skin care: The NICU environment is overwhelming for families. Provide consistent, clear explanations of what is happening and why each intervention is in place. Skin-to-skin (kangaroo) care is beneficial once the infant is stable enough — typically when off mechanical ventilation or on stable CPAP — improving temperature regulation, weight gain, breastfeeding rates, and parental bonding. Neonatal jaundice monitoring is also relevant for preterm infants as they transition off respiratory support; see neonatal jaundice nursing.

Sepsis co-management: Because GBS pneumonia mimics RDS clinically and radiographically, most NICU protocols call for empiric antibiotics (ampicillin + gentamicin) until blood culture results are available at 48 hours. The nurse draws cultures before antibiotic administration, verifies timing of the first dose, and monitors for culture results that may clarify the diagnosis. See neonatal sepsis nursing for the full sepsis framework.

Connections to adult respiratory nursing: The core concepts of lung compliance, PEEP, FiO2 titration, and oxygen toxicity in RDS parallel those in adult ARDS nursing. The mechanical differences (neonatal lung size, different ventilator modes, surfactant therapy) are substantial, but understanding the shared physiology deepens understanding of both conditions. For community-acquired pneumonia comparison and differential, see pneumonia nursing.

NCLEX tips

These are the highest-yield RDS testing points for NCLEX, covering pathophysiology, clinical recognition, safe oxygen management, and pharmacology.

1. Surfactant deficiency is the primary cause of RDS. Type II pneumocytes produce surfactant, but they are functionally immature before 34–36 weeks of gestation. This is the root cause of RDS — not infection, not fluid overload, not cardiac disease.

2. The classic CXR pattern is ground-glass opacity with air bronchograms. This bilateral, diffuse, fine granular haziness with visible bronchi on CXR is the radiographic hallmark of RDS. If a question describes this CXR in a preterm infant with respiratory distress, the diagnosis is RDS until proven otherwise.

3. Nasal CPAP is first-line for moderate RDS — not intubation. NCLEX frequently tests whether students know that immediate intubation is not the default response. CPAP maintains alveolar recruitment non-invasively. Intubation is reserved for infants who fail CPAP or require surfactant via the INSURE technique.

4. SpO2 target in preterm infants (<37 weeks) is 91–95%. Too high (>95%) causes ROP through retinal hyperoxia-induced vasoconstriction and neovascularization. Too low (<88%) causes hypoxia, IVH risk, and metabolic acidosis. Know this range cold.

5. Betamethasone given to the mother 24 hours to 7 days before preterm delivery reduces RDS incidence by ~50%. It accelerates fetal Type II pneumocyte maturation and surfactant production. NCLEX may ask who receives the drug (the mother, not the infant) and the optimal timing window.

6. After surfactant administration, assess immediately for rapid compliance change. As the surfactant takes effect, the lungs become more compliant and tidal volumes increase. If ventilator settings are not adjusted downward, the infant is at risk for barotrauma and hyperinflation. Also reassess ETT position — the bolus administration can shift the tube.

7. BPD (bronchopulmonary dysplasia) is the most common chronic complication of RDS. Defined as oxygen dependency at 36 weeks corrected gestational age. Caused by a combination of lung immaturity, oxygen toxicity, and ventilator injury. Prevention relies on gentle ventilation, oxygen targeting, and early CPAP.

8. Grunting is physiological PEEP. The infant is exhaling against a partially closed glottis to maintain positive end-expiratory pressure and prevent alveolar collapse. Grunting is not a benign finding — it indicates the infant is working hard to compensate for lung disease. Worsening or louder grunting signals deteriorating respiratory status.

9. RDS risk decreases sharply with gestational age and becomes rare after 35–36 weeks. An infant at 34 weeks has a much higher RDS risk than one at 36 weeks. An infant at 38 weeks presenting with respiratory distress is far more likely to have TTN, GBS pneumonia, or another cause — not RDS.

10. Distinguish RDS from TTN on the time course and CXR. RDS worsens over the first 24–72 hours without treatment; TTN improves spontaneously. RDS shows ground-glass opacity on CXR; TTN shows perihilar streaking. RDS requires active respiratory support and often surfactant; TTN typically resolves with supplemental oxygen alone. Born by cesarean at term = think TTN first.

For the full neonatal assessment framework, initial stabilization, and NICU orientation content, return to the neonatal nursing reference. For delivery room resuscitation steps, see neonatal resuscitation nursing.